mixed bacterial vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2007 (NCT00623831)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Streptococcus pyogenesImmunity, active
Streptococcus pyogenes immunity, active
- Serratia marcescensImmunity, active
Serratia marcescens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mixed bacterial vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00623831 | Phase 1 | May 1, 2007 | J. W. Goethe University, Ludwig Institute for Cancer Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| J. W. Goethe University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1